NCT05601440 2026-02-11
Liquid-biopsy Informed Platform Trial to Evaluate CDK4/6-inhibitor Resistant ER+/HER2- Metastatic Breast Cancer
Canadian Cancer Trials Group
Phase 2 Recruiting
Canadian Cancer Trials Group
ETOP IBCSG Partners Foundation
European Organisation for Research and Treatment of Cancer - EORTC